{"filings":[{"id":1967730,"accession_number":"0001171843-26-005081","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-07-30T20:05:18+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 rev up 12% (ex-reimb), EPS $0.60 vs $0.52; raises FY guidance, boosts buyback by $50M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenues before reimbursements $148.9M (+12% YoY); net income $29.4M ($0.60 diluted EPS) vs $26.6M ($0.52).","EBITDA margin improved to 28.7% of rev before reimb vs 27.8% a year ago; utilization 74%.","Raises FY2026 guidance: rev before reimb growth 9-10%, EBITDA margin 27.8-28.1%.","Board declares $0.31 quarterly dividend (payable Sept 18) and adds $50M to share repurchase authorization.","Strong demand in AI-related user research, utility infrastructure, and reactive work in consumer/chemicals/transport."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":972637,"accession_number":"0001171843-26-004036","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-06-10T20:05:18+00:00","items":["5.07"],"status":"ready","headline":"Exponent annual meeting results: all director nominees elected, KPMG ratified, say-on-pay passes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected six directors: Brown, Corrigan, Lindstrom, Richardson, Schlenker, Zumwalt; each received >40M votes for.","Ratified KPMG as independent auditor for FY ending Jan 1, 2027: 44.6M for, 0.5M against.","Advisory say-on-pay for fiscal 2025 approved with 40.4M for, 0.8M against.","Karen Richardson appointed Chairman of the Board; audit committee chaired by George Brown."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99205,"accession_number":"0001171843-26-002896","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenue up 14% to $166.3M; EPS $0.59; declares $0.31 dividend, adds $50M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue before reimbursements $151.8M (+10% YoY); net income $29.6M ($0.59 diluted EPS) vs $26.7M ($0.52).","EBITDA $43.1M (28.4% of net rev) vs $37.5M (27.3%) in prior year; 76% utilization.","Engineering & scientific segment +12% YoY driven by AI consumer electronics studies and utility risk mgmt; env/health +2%.","Q2 guidance: revenue growth high-single digits; EBITDA margin 27.0%-27.8%; FY2026 outlook maintained.","Dividend $0.31/share payable June 18; additional $50M buyback authorization, total ~$67.7M available."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":166303000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99204,"accession_number":"0001171843-26-002263","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Exponent appoints John Pye as President, Eric Anderson as CFO; Paul Johnston retiring","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Pye appointed President effective May 1, 2026; base salary $650,000; receives 21,000 stock options vesting over 4 years.","Eric Anderson appointed CFO effective May 1, 2026; base salary $525,000; receives 12,600 stock options vesting over 4 years.","Rich Schlenker steps down as CFO but remains EVP; nominated to Board of Directors.","Paul Johnston to retire from Board at June 4, 2026 Annual Meeting; Karen Richardson becomes Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115081,"accession_number":"0001171843-26-000654","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 revenue $147.4M (+7.8%), EPS $0.49; FY revenue $582M; dividend raised to $0.31","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $147.4M, up 7.8% YoY; net income $24.8M, diluted EPS $0.49 vs $0.46.","Fiscal 2025 total revenues $582.0M, up 4.2%; net income $106.0M, diluted EPS $2.07.","Engineering & scientific segment rev before reimbursements up 7% in Q4; environmental & health down 5%.","Quarterly dividend increased to $0.31/share, payable March 20, 2026 to holders of record March 6.","FY2026 guidance: rev before reimbursements growth high-single digits; EBITDA margin 27.6%-28.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":582014000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131470,"accession_number":"0001171843-25-006835","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 net revenue up 10% YoY; raises FY2025 margin guidance; adds $100M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $147.1M; revenues before reimbursements up 10% to $137.1M; net income $28.0M ($0.55 EPS) vs $26.0M ($0.50 EPS) a year ago.","Engineering segment (84% of rev) and environmental/health segment each grew 10% and 9% respectively in Q3.","Full-year FY2025 guidance: revenues before reimbursements low single-digit growth; EBITDA margin raised to 27.4%-27.65%.","Board declared $0.30/share dividend payable Dec 19, 2025 (record Dec 5); also authorized additional $100M share repurchase.","YTD 2025: $46.7M dividends paid, $72.7M stock repurchased; cash and equivalents at $207.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":434589000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148060,"accession_number":"0001171843-25-004918","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 EPS $0.52 vs $0.57 YoY; revenues flat, guides Q3 mid-single digit growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $0.52 (down from $0.57); net income $26.6M vs $29.2M in Q2 2024.","Revenue before reimbursements flat at $132.9M; total revenue $142.0M (+1% YoY).","EBITDA margin fell to 27.8% from 30.2%; environmental/health segment down 4%.","Q3 guidance: rev before reimb up mid-single digits; EBITDA margin 26.75%-27.75%.","Declares $0.30 quarterly dividend payable Sept 19, 2025; record Sept 5."],"consensus_eps_estimate":null,"consensus_eps_actual":1.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":287469000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166804,"accession_number":"0001171843-25-003818","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent holds annual meeting; elects all six director nominees","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected: Brown, Corrigan, Johnston, Lindstrom, Richardson, Zumwalt.","KPMG ratified as independent auditor for fiscal 2025 with 46.7M votes for (97% of votes cast).","Advisory vote on executive compensation approved with 41.97M for vs 1.85M against.","No other material changes; shares outstanding as of record date: 50,757,382."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166803,"accession_number":"0001171843-25-002692","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenue flat at $145.5M; EPS down to $0.52; Q2 revenue guided down low-single digits","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues flat at $145.5M; revenues before reimbursements flat at $137.4M YoY.","Net income $26.7M ($0.52 diluted EPS) vs $30.1M ($0.59) in Q1 2024; negative tax impact of $0.5M.","EBITDA $37.5M (27.3% of net revenues) vs $40.1M (29.2%) in Q1 2024.","Guides Q2 revenues before reimbursements down low-single digits; full year low-single digit growth maintained.","Quarterly dividend of $0.30 per share declared, payable June 20, 2025 to holders of record June 6, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":145507000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184207,"accession_number":"0001171843-25-000676","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 rev up 11% to $136.8M; EPS $0.46; div raised to $0.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $23.6M ($0.46 diluted EPS) vs $20.9M ($0.41) a year ago; rev before reimb $123.8M (+8.7%).","FY2024 net income $109.0M ($2.11 diluted EPS) vs $100.3M ($1.94); rev before reimb $518.5M (+4.3%).","EBITDA margin improved to 28.4% for FY2024 (27.7% prior); Q4 EBITDA margin 25.2% vs 26.8%.","Guides Q1 2025 rev before reimb down low-single-digits; FY2025 rev growth low-single-digits, EBITDA margin 26.25-27.0%.","Quarterly dividend raised 7.1% to $0.30 from $0.28, payable March 21; 12th consecutive annual increase."],"consensus_eps_estimate":null,"consensus_eps_actual":2.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":558514000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200807,"accession_number":"0000950170-24-119889","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent's Group VP Eric Guyer resigns effective Nov 8, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Guyer, Ph.D., Group Vice President, resigned October 28, effective November 8, 2024.","No reason for resignation provided; no successor named in the filing.","Exponent, Inc. (EXPO) trades on Nasdaq Global Select Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200806,"accession_number":"0001171843-24-005815","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 net income up 6% to $0.50 EPS; revenue flat; raises FY EBITDA margin guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenues before reimbursements $125.1M (flat YoY); net income $26.0M (+6%, $0.50 diluted EPS vs $0.48).","EBITDA margin 28.6% (+100bps); utilization 75% in first nine months.","Engineering segment flat; environmental/health down 6% on chemical/life sciences headwinds.","FY2024 rev growth guided low-to-mid single digits; EBITDA margin raised to 27.9%-28.1%.","Dividend $0.28/share, payable Dec 20, record Dec 6 (unchanged from prior quarter)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":421748000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216811,"accession_number":"0001171843-24-004151","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 net income up 14% to $0.57 EPS; raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net income $29.2M ($0.57 EPS) up 14% YoY; revenue flat at $140.5M.","EBITDA margin expanded to 30.2% of revs before reimbursements vs 28.4% YoY.","Raised FY 2024 guidance: revs before reimbursements low-mid single digit growth; EBITDA margin 27.5%-28.0%.","Quarterly dividend declared at $0.28/share, payable Sep 20, record Sep 6.","Engineering & other scientific segment revs up 4% in Q2; environmental & health down 4%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":285469000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236536,"accession_number":"0000950170-24-076817","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Exponent extends Arizona lease to 2043; annual rent rises to $6.2M from $1M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Lease extension for 15 years starting Jan 17, 2028 through Jan 16, 2043.","Current annual rent of $1,009,000 holds until Jan 16, 2028; then jumps to $6,183,325 per year.","Rent adjusted every 5 years based on CPI, with first adjustment in 2033.","Lessee retains right to remove vertical improvements; no additional rent for improvements during extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236535,"accession_number":"0000950170-24-071983","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent shareholders re-elect all six directors; approve equity plan amendment to increase shares to 13.34M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected; Karen Richardson appointed Lead Independent Director and Paul Johnston Chairman.","Shareholders ratified KPMG as auditor for FY2024 (47,890,461 for, 524,035 against) and approved advisory say-on-pay (41,591,520 for).","Amendment to 2008 Equity Incentive Plan approved, increasing authorized shares to 13,336,300 (43,635,280 for).","Committee chairs set: Brown (audit), Lindstrom (nominating/corp gov), Zumwalt (HR)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236534,"accession_number":"0001171843-24-002240","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revs before reimbursements up 6.6% to $137.2M, EPS $0.59, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $144.9M (+3.3% YoY); net income $30.1M ($0.59 diluted EPS) vs $29.1M ($0.56).","EBITDA margin improved to 29.2% ($40.1M) from 27.8% ($35.8M); utilization 75%.","Engineering segment (84% of rev) grew 8% in rev before reimbursements; environmental/health (16%) grew 1%.","Q2 2024 guidance: rev before reimbursements flat to low-single-digit growth; EBITDA margin 27.25%-28.25%.","FY2024 guidance raised: low-single-digit revenue growth, EBITDA margin 26.25%-27.0% (increased from prior range)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":144933000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254168,"accession_number":"0000950170-24-023858","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-03-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent appoints Brian Kundert as Chief Human Resources Officer effective March 16, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Kundert, 49, appointed CHRO effective March 16, 2024.","Kundert joined Exponent as VP, HR on July 10, 2023; previously Global Director of HR at Arcadis.","Appointment fills role that may have been vacant or newly created; no prior CHRO named in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254167,"accession_number":"0000950170-24-012433","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent CHRO Sally Shepard to retire effective March 15, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sally Shepard is stepping down as Chief Human Resources Officer on March 15, 2024.","No replacement has been announced as of the filing date.","The retirement was disclosed in a Form 8-K filed February 7, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254166,"accession_number":"0001171843-24-000521","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 net income down to $0.41 EPS; raises dividend to $0.28, adds $61.6M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenues before reimbursements $113.9M (+1.1% YoY); net income $20.9M ($0.41 diluted EPS) vs $22.5M ($0.44) prior year.","FY2023 net revenues $497.2M (+7.2%); net income $100.3M ($1.94 diluted EPS) vs $102.3M ($1.96).","Guidance: FY2024 revenues before reimbursements flat to down low-single digits; EBITDA margin 25.75%-26.5%.","Quarterly dividend raised to $0.28 from $0.26, payable March 22, 2024; record March 8, 2024.","Board authorized additional $61.6M for share repurchases, total authorization $100M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.94,"consensus_revenue_estimate":null,"consensus_revenue_actual":536766000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271638,"accession_number":"0001171843-23-006473","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 revenue before reimbursements $125.0M (+9% YoY); EPS $0.48 flat; full-year guidance reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenues before reimbursements $125.0M (+9% YoY); net income $24.5M ($0.48 diluted EPS) vs $24.4M ($0.47) prior year.","Engineering & other scientific segment +8% YoY; environmental & health +13%; consumer electronics softness noted.","Full-year FY2023 outlook: revenue before reimbursements high-single-digit growth; EBITDA margin 27.4%-27.8%.","Quarterly dividend $0.26/share declared, payable Dec 22, record Dec 8 (unchanged from prior rate).","Cash $137.1M at quarter end; $17.0M in share repurchases and $40.9M in dividends paid YTD."],"consensus_eps_estimate":null,"consensus_eps_actual":1.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":413866000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271637,"accession_number":"0000950170-23-052421","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-10-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent Group VP Steven J. Murray resigns effective Oct 13, 2023","summary_kind":"llm","event_type":"leadership","confidence":"medium","bullets":["Steven J. Murray, Ph.D., Group Vice President, resigned on Oct 2, 2023; effective Oct 13, 2023.","Murray was a named executive officer of Exponent.","No replacement or reason for departure disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288494,"accession_number":"0000950170-23-047341","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K/A","filed_at":"2023-09-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent board adopts annual say-on-pay advisory votes after stockholder recommendation","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders at June 8, 2023 annual meeting recommended say-on-pay advisory votes every 1 year.","Board of directors determined future say-on-pay advisory votes will be held annually.","This 8-K/A amends the original June 13, 2023 filing solely to disclose the board's frequency decision.","No other changes were made to the original Form 8-K reporting meeting results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288495,"accession_number":"0001171843-23-004740","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 rev before reimb +9.7% to $129.7M, EPS $0.50; FY guidance maintained","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $140.2M (+7.6% YoY); revenues before reimbursements $129.7M (+9.7% YoY).","Net income $25.7M ($0.50 diluted EPS) vs $25.8M ($0.49) in Q2 2022; tax rate 29.0%.","EBITDA margin fell to 28.4% of rev before reimb from 31.4% YoY; headcount up 15%.","Engineering & sci segment rev before reimb +10% YoY; environmental & health +10% YoY.","Board declared $0.26/share quarterly dividend, payable Sept 22, record Sept 8."],"consensus_eps_estimate":null,"consensus_eps_actual":1.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":280530000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309025,"accession_number":"0000950170-23-027632","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent stockholders elect all director nominees and ratify KPMG at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Six directors elected: Brown, Corrigan, Johnson, Lindstrom, Richardson, Zumwalt; each received >43M votes for.","KPMG ratified as auditor for fiscal 2023 with 47.2M votes for, 0.85M against.","Advisory say-on-pay approved (41.6M for, 2.5M against); annual frequency selected (42.8M votes for one year).","Broker non-votes for director and advisory proposals totaled 4,040,513."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309024,"accession_number":"0001171843-23-002639","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenues $140.3M (+9.2% YoY), EPS $0.56; reiterates FY23 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues before reimbursements $128.7M, up 9.2% YoY; net income $29.1M, diluted EPS $0.56 (incl. $0.07 tax benefit).","Engineering segment revenues up 11% YoY (83% of revenues); environmental/health segment down 1% (up 2% ex-FX).","Q2 2023 guidance: revenue growth high-single to low-double digits; EBITDA margin 27.5%-28.5% of rev. Full year unchanged.","Declared quarterly cash dividend of $0.26/share, payable June 23, 2023, record June 9, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":140309000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327788,"accession_number":"0000950170-23-003171","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-02-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent expands board to 7, reappoints Karen Richardson as director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 6 to 7 members on Feb 15, 2023.","Karen Richardson appointed to audit, nominating/corp governance, and HR committees.","Richardson previously served as director from 2013 to June 2022.","Richardson brings 30+ years tech experience; former CEO of E.piphany, VP Sales at Netscape."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327787,"accession_number":"0001171843-23-000631","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2023-02-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 revenue up 12%, net income $22.5M; raises dividend to $0.26/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $127.4M (+12.2% YoY); revenues before reimbursements $112.6M (+7.9%).","Q4 diluted EPS $0.44 vs $0.38; FY2022 diluted EPS $1.96 vs $1.90.","Q1 2023 guidance: rev before reimbursements growth high-single to low-double digits; EBITDA margin 27.5-28.2%.","Dividend raised from $0.24 to $0.26 per share, payable March 24, record March 10, 2023.","In FY2022, repaid $155.9M stock, paid $49.2M dividends; cash $161.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":513293000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345470,"accession_number":"0000950170-22-026691","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Exponent adopts amended bylaws updating advance notice and universal proxy rules","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Updates advance notice requirements for director nominations and stockholder proposals, expanding disclosure and verification.","Requires stockholders to confirm compliance with universal proxy rules; non-compliant nominees' votes may be disregarded.","Clarifies special meeting request aggregation, nominee limit, and stockholder list availability per DGCL updates.","Amended and restated bylaws adopted by board on Dec 15, 2022, effective immediately."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345469,"accession_number":"0001171843-22-006833","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-10-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent reports Q3 revenue up 6.2%, net income flat; narrows FY22 guidance, declares $0.24 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue before reimbursements $115.1M (+6.2% YoY); total revenues $127.2M (+9.3% YoY).","Net income $24.4M ($0.47 diluted EPS) vs $24.6M ($0.46) in Q3 2021; EBITDA margin 30.0% vs 31.4%.","Full-year 2022 guidance narrowed: revenue growth 6%-7%, EBITDA margin down 100-125 bps.","Q4 2022 guidance: revenue growth mid- to high-single digits; EBITDA margin down 175-275 bps YoY.","Declared Q4 cash dividend $0.24/share, payable Dec 23, 2022, record Dec 9, 2022 (unchanged)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":385938000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361921,"accession_number":"0001171843-22-005116","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-07-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 revenue $130.3M (+8.7% YoY), EPS $0.49; declares $0.24 quarterly dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 total revenues $130.3M (+8.7% YoY), net revenues $118.2M (+5.1%); diluted EPS $0.49 vs $0.48.","EBITDA $37.1M (31.4% of net revenues) down 90 bps margin vs Q2 2021.","Q3 guidance: net revenue mid-single digit growth, EBITDA margin down 300-375 bps; FY2022 guidance: mid-to-high single digit net revenue growth, EBITDA margin down 150-200 bps (improved).","Board declares $0.24/share quarterly dividend, payable Sept 23, record Sept 9; $165.6M cash; $106.6M remaining buyback."],"consensus_eps_estimate":null,"consensus_eps_actual":1.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":258759000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381374,"accession_number":"0001564590-22-022484","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-06-03T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent annual meeting votes: directors elected, KPMG ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected with for votes ranging from 44.5M to 45.4M.","KPMG ratified as independent auditor for FY2022 with 48.1M for, 1.1M against.","Advisory say-on-pay proposal approved with 43.8M for, 1.9M against.","Record date April 6, 2022; shares outstanding 51,821,607.","Meeting held June 2, 2022, with broker non-votes of 3.48M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381373,"accession_number":"0001171843-22-002967","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenue up 7.6% to $117.9M; EPS $0.56 vs $0.58; guides FY22 mid-high single-digit revenue growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue before reimbursements $117.9M (+7.6% YoY); total revenue $128.5M (+10.3%).","Net income $29.6M ($0.56 EPS) vs $30.8M ($0.58); tax benefit $6.0M ($0.11) lower than prior year's $8.8M.","EBITDA (non-GAAP) $34.5M (29.2% of net revenues) up from $31.8M (29.0%).","Repurchased $48.6M of stock; declared quarterly dividend of $0.24/share, payable June 24.","FY22 guidance: revenue growth mid- to high-single digits; EBITDA margin down 200-250 bps; Q2 revenue mid-single."],"consensus_eps_estimate":null,"consensus_eps_actual":0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":128478000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399372,"accession_number":"0001171843-22-001262","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-02-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Exponent increases share repurchase authorization by $150M to $179.5M total available","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized additional $150M share repurchase, bringing total authorization to $179.5M.","Company has repurchased $38.9M of common stock in fiscal 2022 to date.","CEO cites strong cash position ($297.7M at end of FY2021) and recent 20% dividend increase.","Authorization covers open market or privately negotiated transactions per Rule 10b-18."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399371,"accession_number":"0001171843-22-000757","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2022-02-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 net income $20.4M ($0.38 EPS); FY net revenue up 15%, dividend raised 20% to $0.24/quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2021 revenues before reimbursements $104.3M (+7.2% YoY); net income $20.4M ($0.38 diluted EPS) vs $21.8M ($0.41) in Q4 2020.","FY2021 net revenue $434.9M (+14.9%), net income $101.2M ($1.90 EPS) up from $82.6M ($1.55) in FY2020.","EBITDA margin FY2021 30.4%, up 343 bps YoY; Q4 2021 EBITDA margin 28.9%.","Guidance: Q1 2022 net revenue growth mid-to-high single digits; FY2022 net revenue growth same with EBITDA margin down 200-250 bps.","Quarterly dividend raised 20% to $0.24 per share, payable March 25, 2022 to holders of record March 11, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":1.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":466269000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418355,"accession_number":"0001171843-21-007272","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2021-10-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 net revenue up 16% to $108.5M; EPS $0.46 vs $0.34; EBITDA margin 31.4% vs 27.8%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 FY2021 net income $24.6M ($0.46 diluted EPS) vs $18.1M ($0.34) in Q3 2020.","Total revenues $116.4M (+18% YoY); revenues before reimbursements $108.5M (+16% YoY).","EBITDA $34.0M (31.4% of net revenues) vs $26.0M (27.8%) last year; margin +360bps.","Guidance: Q4 net revenue growth mid-single digits YoY; EBITDA margin -175 to -225 bps; full year net revenue growth mid-teens, EBITDA margin +290-310 bps.","Board declares $0.20/share quarterly dividend, payable Dec 17, 2021 to holders of record Dec 3, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":352763000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435915,"accession_number":"0001171843-21-005289","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2021-07-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 net rev $112.5M (+28% YoY), EPS $0.48; declares $0.20 dividend; raises FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues before reimbursements up 28% YoY to $112.5M; net income $25.4M vs $16.3M.","Diluted EPS $0.48 vs $0.31; EBITDA margin expanded 630 bps to 32.3%.","Engineering & scientific segment net rev +33%; environmental & health +9%.","Guides Q3: revenue low-double-digit growth, EBITDA margin +100-150 bps.","Board declares quarterly cash dividend $0.20/share, payable Sept 24 to holders of record Sept 10."],"consensus_eps_estimate":null,"consensus_eps_actual":1.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":236358000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}